… IL-6 … ] At the clinical introduction of TCZ in the treatment of COVID-19 induced CSS its
non-labelled application sparked controversy.[10] In accordance with our findings based on clinical …

… responses of ARDS during cytokine storms in COVID-19 … characteristics and mechanisms of
cytokine storms, host responses… little clinical data available in regard to evidence for cytokine …

… obtain EVs with specific (viral) surface proteins that is able to target lung cells and how to
scale up the production of EV-based vaccines so that we have sufficient quantities for clinical …

… release of cytokines, chemokines and growth factors. This cytokine storm creates an …
progression of the clinical studies using these products in COVID-19 (if clinical trials were registered …

… Taking into consideration the multisystemic clinical and … term to describe the whole clinical
picture. The most significant … be effective in the treatment of cytokine storm, but some patients …

… clinical manifestation of COVID-19 and require hospitalization in intensive care units may
have a cytokine storm … According to this consideration, it might be more beneficial to start the …

… clinical deterioration and eventual death in these patients. While most studies have attributed
the pathological damage to the lung to be primarily due to high levels of cytokines … cytokine …

… considerations should be noted between COVID-19- associated CS and many other CS
disorders. Cytokine storm … block individual cytokines to achieve the desired clinical benefit given …

… immune cells, inducing a cytokine storm [7]. Severe … cytokine storm syndrome, leading to
increased risk of mortality. The characteristics and clinical manifestations of this cytokine storm …

… Secondary multisystem inflammatory disease or cytokine storm syndrome was diagnosed
based on clinical symptoms, lymphopenia, anaemia, thrombocytopenia, increased acute-…